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Manythousandsofchemicalsareproducedindustriallyandmanymoreoccurnaturally.Informationonthetoxicology
ofthesechemicals isoftenminimalorabsent. TheInternational Agency forResearch onCancer (IARC) haspublished
evaluationsofthecarcinogenic risktohumansofover700chemica4groupsofchemicals,andcompex mixturesasaregular
seriesofmonographs. Adatabase hasbeencreatedcontainingsummaniesofalltherelevantepidemiological,animalcar-
cinogenicity, andotherrelevantbiologicaldataforeachchemicalormixtureevaluated. Additionaldatabaseshavebeen
createdforongoingepidemiological studiesofcancerinhumans andforlong-termcarcinogenicity studiesinrodents, as
wellasadatabasecontalninginformationongenotoxic andrelatedeffectsofchemicals. Someofthesedatabases havebeen
publishedinprintform. IARC nowplanstopublishthemelectronically,togetherwithotherdatabases, intheformofa
CDROM (compactdisk, read-only memory). TheobjectivewillbetomaketheentireIARCdatabaseofcancerinformation
as widely available as possible in an integrated format conducive toefficient andcombined exploitationofall the com-
ponent databases.
Introduction: Chemicals, Carcinogens,
and Hazards to Humans
Estimates vary as tothenumberofchemicalsthat areproduced
in significant amounts. In 1980, the European Core Inventory
(ECDIN) listedabout34,000chemical substancesbelievedtobe
on the European Community market (1). Later, Shulze and
Mucke (2) estimated thatthere wereabout 100,000chemicals on
the market within the European Community. Recently, it has
beenestimated onthebasis ofthe U.S. Toxic Substance Control
Act inventory that people in the United States are exposed to
about66,000chemical substances (3), and some 300to700 new
industrial chemicals are introduced annually intoeconomnic use
(4). Thefactthat evenminimaltoxicitydata areavailableforonly
aminority ofthese chemicals is due totherapiddevelopmentof
new industrial activities during a period in which health prob-
lems related tochemicalsreceived littleattention. Several thou-
sandchemicals onthemarkethavebeentested to someextentfor
carcinogenicity in long-term animal studies; however, the
numberofchemicals testedadequately and forwhichthere are
publications in the open literature is much lower. It should be
noted that a small proportion ofall the chemicals accounts for
mostoftheproduction: forinstance, 380primary derivativesof
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petroleumproducts accountformorethanhalfoftheproduction
tonnage ofall chemicals (5).
TheInternational Agency forResearchonCancer(IARC) has
beeninvolvedinpreparinganddisseminating scientific informa-
tionrelevanttocancercontrolformorethan25years. Duringthis
period, extensive collections of data on carcinogenicity and
related effects ofchemicals and specific exposures have been
madeavailabletothescientificcommunityasaseriesofover50
volumesofIARCMonographsontheEvaluationofCarcinogenic
RiskstoHumans(6). Duringthepreparationandperiodicalup-
dating of these carcinogenicity evaluations, several ancillary
databases have been developed and maintained alongside the
IARCMonographs themselves, mainly for internal use. Inthis
briefreview,wedescribethenatureandcontentofthesedatabases
anddiscusssomeoftheperspectivesfortheirfuturedevelopment.
The IARC Databases
TheIARCMonographs on theEvaluation of
Carcinogenic Risksto Humans
TheobjectiveoftheIARCMonographs programis topublish
critical reviews of data on carcinogenicity for chemicals and
complexmixturestowhichhumansareknowntobeexposedand
onspecificculturaloroccupationalexposures; toevaluatethese
dataintermsofhumanriskwiththehelpofinternational work-
ing groups of experts in chemical carcinogenesis and related
fields; and, insomecases, toindicatewhereadditionalresearch
efforts areneeded. By theendof1990, 50volumesoftheIARC
Monographs (6) had been published, and three more were in
preparation, containingdetailedevaluations ofcarcinogenicityVAINIO ETAL.
on 732 chemicals, groups ofchemicals, complex mixtures and
cultural/occupational exposure circumstances.
Until 1987, evaluations ofcarcinogenicity weremade separate-
ly onthehumanandexperimental data: no attempt wasmade to
produce an overall evaluationofcarcinogenicity tohumans. At
a special meeting in 1987, re-evaluations ofavailable new data
weremade on 189 agents, mixtures, or exposurecircumstances
for which there were at least some data available on cancer in
humans, taking account ofall available evidence. At the same
time, overallevaluationsofcarcinogenicity tohumans weremade
for all 628 agents/mixtures/exposures (comprising more than
700 chemicals, groups ofchemicals, mixtures, orcultural and
occupationalexposures) evaluated so far inthe program. Overall
evaluations ofcarcinogenicity tohumanshavebeenmadebyeach
working group from volume 43 onwards.
This evaluation process has resulted in categorization ofthe
carcinogenicity ofeachchemical, groupofchemicals orcomplex
mixture or exposure circumstance into one offive categories:
group 1, the agent, mixture, or exposure circumstance is car-
cinogenic tohumans (acausal relationship hasbeenestablished
between exposureandhumancancer); group2A, theagent, mix-
ture or exposure circumstance is probably carcinogenic to
humans (a positive association has been observedbetween ex-
posure and human cancer for which a causal interpretation is
credible, butchance, bias, orconfoundingcouldnotberuledout
with reasonableconfidence; thereisalso sufficient evidence of
carcinogenicity in experimental animals. Exceptionally, this
category may be used when there is sufficient evidence ofcar-
cinogenicity in animals strengthened by supporting evidence
from other relevant data); group 2B, the agent, mixture or ex-
posurecircumstance ispossiblycarcinogenic tohumans (there
issufficientevidenceofcarcinogenicity inexperimentalanimals,
but noadequatedata on cancer inexposedhumans; in somein-
stances, an agent for which there is inadequate or no data in
humans, but with limited evidence of carcinogenicity in ex-
perimental animals, maybeplacedintothis category whenthere
is supporting evidence from other relevant data); group 3, the
agent, mixture or exposurecircumstance isnotclassifiable asto
its carcinogenicity tohumans (this groupapplieswhen noother
category is used); group4, the agent, mixture or exposure cir-
cumstance is probably not carcinogenic to humans (there is
evidence suggesting lackofcarcinogenicity inhumanstogether
withevidencesuggestinglackofcarcinogenicity inexperimen-
talanimals; in someinstances, an agentforwhichthereisinade-
quate evidence or no data on carcinogenicity in humans but
evidence suggesting lack of carcinogenicity in experimental
animals, consistently and strongly supportedby abroad rangeof
otherrelevantdata, maybeplacedinthiscategory). Table 1 gives
the distribution of all the agents evaluated up to 1990 (IARC
Monographs volumes 1-53) into these five categories.
Thecategorizations giveninTable 1 areclearlyrelated to ex-
posure and not to a specific target organ. This is because the
primary goal ofthe IARCMonographs program is to reach an
evaluation ofcarcinogenicityperse, andtheworkingprocedures
used do not embody provision to classify exposures as to their
carcinogenicity forspecifiedtargetorgans. However, foranagent
tobeclassified in group 1, there mustbeatleast onetargetorgan
for which sufficient evidence ofcarcinogenicity in humans is
judged toexist(Table2). Similarly, forall agentsjudged tohave
Table 1. Overall evaluations of carcinogenicity to humans in the IARC
Monographsprogrm (volumes1-53): distributionofagentsandexposures
bycategory.t
Carcinogenic tohumans (group 1) 55
Probably carcinogenic to humans (group2A) 45
Possibly carcinogenic to humans (group 2B) 191
Cannotbeclassified as to itscarcinogenicity to humans (group 3) 440
Probably notcarcinogenic to humans (group4)b 1
Total 732
aThe evaluations in the IARC Monographs are qualitative, reflecting the
strengthoftheevidenceastothecarcinogenicityoftheagentconcernedderived
fromstudies inhumansand inexperimentalanimalsandfromotherrelevantdata.
This means that the assessment is ofthe strength ofevidence as to whether a
substance iscarcinogenic, notastothedegree, ifany, towhichitiscarcinogenic.
bCriteria for selection ofagents evaluated intheIARCMonographs is based
mainlyonasuspicionofcarcinogenicity aspublished inthescientific literature.
sufficientevidenceofcarcinogenicity inexperimental animals,
thejudgment is usually based on evidence from one or more
species. Targetorgansmaydifferfromonespeciestoanotherfor
many exposures causally related to human cancers; however,
there is almost always at least one organ in common between
humansandatleastone animal species, despite many inherent
physiological differences between species (7).
IARCMonographs CompoundDatabase
Acomputerizeddatabasehasbeencreatedforallchemicals,
groupsofchemicals, complexmixtures, orexposuresevaluated
involumes 1-53 oftheIARCMonographs. Foreach agent, the
database contains the Chemical Abstracts Service Registry
Number (CAS number), the chemical name, monographs
reference (volume, year, page) and supplement 7 reference
(page). Inaddition, thefollowing dataarepresented in indexed
format and can be searched using boolean logic: a) overall
evaluationofcarcinogenicity tohumans; b)degreeofevidence
ofcarcinogenicity in humans and in animals (according to the
criteria given in the Preamble to the IARCMonographs); c)
chemical class-main molecular structural group(s); d) use
class-mainindustrial useorexposurecircumstance; e) foreach
report/experiment considered in the evaluation, the species,
route ofexposure, target organ, certainty (degree ofevidence
evaluation for the organ concerned), tumor type and biblio-
graphical citation;J) short-term test and related data: phylo-
genetic level, genetic and related end point, result; and g)
teratogenicity, embryotoxicity, and fetotoxicity data.
LARC/EPA Genetic Activity Profiles
ThedatausedintheIARCMonographsongeneticandrelated
effectshavebeenpreparedtogetherwiththeU.S. Environmen-
talProtectionAgency (EPA)intheformofgeneticactivitypro-
files(8,9)andstoredinaseparatedatabase. Thetestresultshave
been verified by the IARCMonographs working groups. The
completedatarecordforeachchemicalagentincludesthename
andCAS number, testcode, endpoint, testresultswith activa-
tioninvitro,highestineffectivedoseorlowesteffectivedose, and
reference. The graphic display ofdata was modified from the
methodofGarrettetal. (10) forIARC purposes. By theendof
1990, theIARC/EPAdatasetcontaineddataon299agentscon-
sideredinsupplement6 totheIARCMonographsandvolumes
46-50ofthe series.
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Table2. Established humancarcinogensandtheirtargetorgans.
Taraet oraan (susnected tarvet oraan) in humans
Agents
Aflatoxins
4-Aminobiphenyl
Arsenic and arsenic compoundsa
Asbestos
Azathioprine
Benzene
Benzidine
N,N-bis(2-chloroethyl)-2-naphthylamine (chlornaphazine)
Bis(chloromethyl)ether andchloromethyl methyl ether (technical grade)
1,4-Butanediol dimethanesulfonate (myleran)
Chlorambucil
1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-l-nitrosourea (methyl-CCNU)
Chromium(VI) compounds
Cyclosporin
Cyclophosphamide
Diethylstilbestrol
Erionite
Melphalan
8-Methoxypsoralen (methoxsalen) plus ultraviolet radiation
MOPP andother combined chemotherapy including alkylating agents
Mustard gas (sulfur mustard)
2-Naphthylamine
Nickel compounds
Estrogen replacement therapy
Estrogens, nonsteroidala
Estrogens, steroidala
Oral contraceptives, combinedb
Oral contraceptives, sequential
Radon and its decay products
Talc containing asbestiform fibres
Thiotepa
Treosulphan
Vinyl chloride
Mixtures
Alcoholic beverages
Analgesic mixture containing phenacetin
Betel quid with tobacco
Coal-tarpitches
Coal tars
Mineral oils, untreated and mildly treated
Shale oils
Soots
Tobacco products, smokeless
Tobacco smoke
Exposure circumstances
Aluminum production
Auramine manufacture
Bootand shoe manufacture and repair
Liver (lung)
Bladder
Lung, skin
Lung, pleura, peritoneum (gastrointestinal tract, larynx)
Lymphatic system, mesenchyma, hepatobiliary system, skin
Hematopoietic system
Bladder
Bladder
Lung
Hematopoietic system
Hematopoietic system
Hematopoietic
Lung (nasal cavity)
Lymphatic system
Bladder, hematopoietic system
Cervix/vagina, breast, testis (uterus)
Pleura, peritoneum
Hematopoetic system
Skin
Hematopoietic system
Pharynx, larynx, lung
Bladder(liver)
Nasal cavity, lung
Uterus (breast)
Cervix/vagina, breast, testis (uterus)
Uterus (breast)
Liver
Uterus
Lung
Lung
Hematopoietic system
Hematopoietic system
Liver, blood vessels (brain, lung, lymphatic system)
Pharynx, esophagus, liver, larynx, oral cavity (breast)
Bladder, kidney
Oral cavity, pharynx, larynx, esophagus
Skin, lung, bladder (larynx, oral cavity)
Skin, lung (bladder)
Skin (lung, bladder, gastrointestinal tract)
Skin (gastrointestinal tract)
Skin, lung
Oral cavity, pharynx, esophagus
Lung, bladder, oral cavity, pharnyx, larynx, esophagus, pancreas, kidney
Lung, bladder (lymphatic system)
Bladder (prostate)
Nasal cavity, hematopoietic system (pharnyx, lung, liver, gastrointestinal tract,
bladder)
Coal gasification Skin, lung, bladder
Coke production Skin, lung, kidney
Furniture and cabinet making Nasal cavity
Iron and steel founding Lung (gastrointestinal tract, genitourinary system, hematopoietic system)
Isopropyl alcohol manufacture (strong-acid process) Nasal cavity (larynx)
Magenta manufacture Bladder
Painter (occupational exposure as a) Lung
Rubber industry Bladder, hematopoietic system (lung, gastrointestinal tract, skin, lymphatic
system)
Underground hematite mining with exposure to radon Lung
aThis evaluation applies to the group ofchemicals as a wholeand not necessarily to all individual chemicals within the group.
bThere is alsoconclusive evidence that these agents have aprotective effect against cancersofthe ovary andendometrium.
CrossIndexofSynonymsandTradeNames
In 1982, a Cross Index ofSynonyms and Trade Names was
published assupplement3 totheIARCMonographs (6) to pro-
vide an easy reference source for the chemicals considered in
volumes 1-26 ofthe series. The cross index was subsequently
updated to include volumes 1-36 (supplement 5) and volumes
1-46(supplement8). Acomputerizeddatabase ofthis cross in-
dex has been created, containing CAS numbers and names,
synonymsandtrade namesforallchemicals orcomplexmixtures
evaluated intheIARCMonographs.
Carcinogen
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The common name ofthe chemical or complex mixture, as
used in the IARCMonographs, is given with a citation ofthe
monographsreferenceinwhichthesubstancewasfirstevaluated,
as well as cross-references to supplement 6 (summary tables,
graphics, and references on genetic and related effects) and to
supplement 7 (updated summary evaluations ofcarcinogenici-
ty tohumans, with references). All synonyms andtradenames
thenrefertothespecific commonname. Thecrossindex isup-
dated atapproximately 4-year intervals.
Directory ofOn-GoingResearch in Cancer
Epidemiology
TheDirectoryofOn-GoingResearch isanannualcompilation
ofbrief, structured abstracts ofcurrentresearchprojects inthe
field of cancer epidemiology obtained by a survey of several
thousand investigatorseachyear. The 1991 edition(11), the 15th
in the series, contains descriptions ofabout 1150 studies being
carriedoutinmorethan80countries. Eightseparateindexespro-
vide access to the projects. In most indexes, studies indexed to
a given entry are subclassified by cancer site. Thefull mailing
address (and, where available, telephone, telex, and telefax
numbers)ofthe900orsoprincipalinvestigatorsareprovidedto
facilitate contacts between research workers.
TheDirectoryofOn-GoingResearch contains thenamesand
addresses ofthe directors ofmore than 20 banks ofbiological
materials capable ofexploitation in epidemiological research,
together with details ofthe nature and size ofthecollection of
biological materials held and the time period over which they
were collected. Italsoprovidesthe namesandaddresses ofthe
directorsofsome240population-basedcancerregistriesready
tocollaborate in epidemiological research.
Theprinted volumeiscurrently distributedtomorethan2000
scientists, libraries, researchunits, andgovernmentagencies. It
iswidelyusedasasourceofcontactsforcollaborativeresearch
projects, scientific meetings, and advice fromcolleagues with
similar interests.
DirectoryofAgentsBeingTestedforCarcinogencity
Due to the long duration and high costs involved in testing
chemicals forcarcinogenicity inanimals, aninternationalques-
tionnaire survey ofinstitutes undertaking such long-term car-
cinogenicitytesting wasinitiatedin 1973. Theobjectiveswereto
avoidunnecessaryduplicationofresearch, toincreasecommuni-
cation amongscientists, andtomakeavailable acensusofboth
the research facilities involved andthe chemicalsbeing tested.
Surveyresultsarearrangedalphabeticallybycountry,city, and
institute. Forevery institute, thechemicalsorcomplexmixtures
are listed inalphabetical order. The data are reported in a six-
column format: a) name (with CAS number and name, syno-
nymsandtradenames); b)usecategory; c)species, strain, and
number ofanimals in treated and control groups; d) purity of
substancebeingtested, exposureroute, anddoselevels; e) star-
tingdateandstageofexperiment;and])principalinvestigator(s).
The following indexes can be used to identify experiments:
epidemiological studies index (cross-reference tohumancancer
studiesofthesamechemical listedintheDirectoryofOn-Going
Research in Cancer Epidemiology); published studies index;
instituteindex; ChemicalAbstractsServiceRegistry Numbers
index; crossindexofnames (synonymsandtradenames) (now
includes all studies that were published, unpublished, discon-
tinued, etc.); andcategories ofuse index.
The DirectoryofAgentsBeing Testedfor Carcinogenicity is
updated at approximately 2-year intervals. Fourteen volumes
havebeenpublishedtodate. DirectoryofAgentsno. 14(12)gives
information on 922 chemicals or agents being tested for car-
cinogenicity from 80 institutes in 20 countries; a total of298
published reports on 242 chemicals or agents are listed.
ElectronicPublication:TheWayForward
ThecombinedutilityoftheinformationintheIARCdatabases
describedheremaybeevenwiderthanappearsfromaconsidera-
tionofeachdatabasealone. Thewholemay begreaterthanthe
sumofthe parts.
The optimal exploitation ofthis large body ofinformation,
however, wouldrequirecreationofasingleelectronicdatabase
containingalltheindividualdatabases. Itshouldnowbepossi-
bletointegrateallthismaterial intoasingle, comprehensiveand
readilyaccessiblesetofauthoritativeinformationonpublished
experimentalandhumanstudies, withexpertevaluationsofcar-
cinogenicity to humans (the IARCMonographs and ancillary
databases), together with up-to-date listings of all current
research inanimals (DirectoryofAgentsBeing Testedfor Car-
cinogenicity) and inhumans (DirectoryofOn-GoingResearch
in CancerEpidemiology). Suchaninformationresourcecould,
forexample, beusedtostreamlinethereviewandevaluationof
current knowledge and to help identify the most effective
research strategies to extend this knowledge.
Manyotherusescouldbedescribedforsuchanintegrateddata
set, but the ability to disseminate the entire IARC database of
cancer research information to a much wider audience than is
currently possible, particularly indeveloping countries, could
beamajoradditionaladvantageofmanagingthedata inthisway.
Itcouldalsopermitregularupdatingand correction.
Thispossibility isunderactiveconsideration. Itwill require
developmentofthedataintwobroaddomains. First, theexistng
databaseswillneedtobecomestructurallyaligned:althoughthey
areconceptuallycoherent,theyhavebeendevelopedindifferent
waysforconventionalpublicationinprintandarestructurallydi-
verse. Second, this conceptual coherence will need to be re-
flected in a search and retrieval program that enables the full
rangeofinformation tobeexploited withouttheneedforcom-
puting skills. Finally, itwillbenecessary tomakethismaterial
available in awidely accessible format at an affordable cost.
InitialExperiments
Initial steps in partial electronic publication of two of the
databases havealready been made: theDirectoryofOn-Going
ResearchinCancerEpidemiologyandthegeneticactivitypro-
filesofcompoundsevaluatedintheIARCMonographsprogram.
Seven ofthe eight indexes ofthe 1989/90 and 1991 directories
were published on a single IBM-compatible diskette and
distributedwitheverycopyoftheprintedDirectoryofOn-Going
Research (11,13). The search software (PROSE, for project
search) wasdevelopedspecially fortheDirectoryofOn-Going
Researchtoprovidesimultaneous searchingofseveralindexes.
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This facilitates identification of projects meeting a precise
description, suchascase-control studiesofbladdercancerand
sweetnersbeingcarriedoutinNorthAmericaorEuropewithin-
formation on tobacco use, a search involving four indexes. It
wouldbeinefficienttosearchforsuchstudiesusingthevarious
indexesintheDirectoryofOn-GoingResearch. Althoughthisin-
itial experiment in providing electronic access to an IARC
database isconsidered successful, there areseverallimitations.
First, itwasnecessarytorestrictthedatatoasinglediskettes
for both financial and practical reasons. It wouldbe tedious to
havetoloadalargenumberofdiskettes intoacomputertoinstall
the softwareandinconvenienttodedicate severalmegabytesof
hard disk space to adatabase likely tobeconsulted only occa-
sionally. Further, tomakethesoftwareaccessibletothewidest
possibleaudience, theoldesttypeofdiskette(360kilobytes, dou-
bledensity) wasused. Evenaftercompression ofthefilesto fit
onasinglediskette, itwasonlypossibletoincludetheindexes.
Asearchthusproducestheserialnumbersoftheprojectabstracts
intheprinteddirectory, whichisthenconsulteddirectly. Despite
theselimitations, electronicaccesstotheDirectoryofOn-Going
Research indexes has elicited apositive reaction from users.
Theresultsofshort-termtestsforallchemicalsevaluatedinthe
IARCMonographs programs havealsobeenpublished inelec-
tronic form, incollaboration withtheEPA. Thesetestsinclude
DNA damage, gene mutation, sister chromatid exchange and
chromosomalaberrations.Thebiologicalsystemsexaminedrange
frombacteriatovariousmammalianspecies, includinghumans,
bothinvitroandinvivo. Resultsarepresentedinbothnumerical
andgraphicalform. Theelectronicversionispublishedasthree
separatediskettesforuseonIBM-compatiblepersonalcomputers.
Electronic Options
Thereareseveral waysinwhichtheinformationdescribedhere
could be made available in electronic form. These include
diskettes, on-line systems, and CDROM (compact disk, read-
only memory).
Useofdiskettes todistributetheindexes, asfortheDirectory
ofOn-GoingResearch, enables morepowerful searchingthanis
possiblewithprintpublication, butithasseveraldrawbacks. To
examinetheresultofasearch, theusermusthavealltheprinted
textsavailableandcannotreview orrefinetheresultsofasearch
beforeexaminingtheoriginal sourcedocuments. Inaddition, a
largenumberofdisketteswouldberequired, whichcomplicates
thetaskofdistribution, computerstorageandregularupdating.
Makingthedatabasesavailableonexistingon-lineinformation
retrieval systems suchas MEDLINE(U.S. National Library of
Medicine) or EUROCODE (European Organization for Re-
searchandTreatmentofCancer) orcreating anewon-linehost
system is another possibility. It would solve the problems of
database sizeandofupdating the database and the search soft-
warebecauseall theseaspectswouldbemanagedattheon-line
source, requiring no action by the user. From theviewpointof
theIARC, however, thisoptionhasthreedrawbacks. First, and
mostimportant, on-line systems aretypically availableonly in
developedcountrieswiththeappropriatetelecommunications in-
frastructure. Second, on-line access is expensive, as the cost
relatestotimeusedonthehostmainframecomputerandonthe
telecommunications system used to establish contact with it,
ratherthan totheinformation supplied. Third, access is some-
timesdifficultbecauseofproblemsintelecommunications, such
aslongwaitingtimesduringpeakperiodsandincompatibilityof
various communications interfaces.
ThepreferredsolutionwouldappeartobeCDROM: thisisthe
least expensive mass data storage mediumdeveloped so far. A
12-cmdiameterdiskcanhold 650megabytes ofdata, which is
theequivalentof250books or 1500floppydiskettes. CDROM
readersareinexpensiveandwidelyavailableandcanbeattached
tomostpersonalcomputersbyastandardconnection. Software
for rapid search of large text databases on CDROM is also
available. CDROM disks conform to a widely accepted inter-
national standard (ISO-9660 or the High Sierra Standard) for
information exchange, which means that problems of com-
patibility between disks and CDROM readers are unlikely.
Finally, provisionofallthetext, indexes, andsoftwareonasingle
CDROM, forusewithpersonalcomputertechnology, whichis
widely available even in developing countries, represents an
attractivewayofmakingtheinformationavailabletothewidest
possibleaudience. ItislikelythatpurchaseoftheCDROMand
hardwareneededtouseitwouldcostlessthanthepurchaseand
despatch of all the books involved (some of which are out of
print).
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